|
|
|
See also:
The history of the ABCD nationwide audit programme |
|
|
|
2016 |
|
|
The second ABCD endobarrier study - the End-OSA study |
The endobarrier in obstructive
sleep apnoea study of patients with diabetes and obstructive
sleep apnoea treated CPAP aims to see if the weight loss
associated with endobarrier treatment allows some patients
with OSA to improve so much that they no longer require CPAP.
This would not only be of considerable benefit to the
patient, but also would represent an NHS cost saving. The
first patient in the study received their endobarrier on 3
June 2016 and this triggered a
BBC news item. Click the link on the left for more
information. |
|
The ABCD
multi-centre endobarrier study - REVISE Diabesity |
This study, entitled
“REVISE-Diabesity” is a multi-centre randomised controlled
trial evaluating the effectiveness of a new device called
endobarrier on patients who
remain poorly controlled and overweight despite GLP-1 receptor
agonist therapy. It is funded by ABCD and is supported by
the NHS, as a National Institute for Health Research (NIHR)
approved study. As of April 2016 the study achieved it's 1
year results which were presented at ENDO 2016 and
the
ABCD Spring meeting in Manchester and the
slides from this can be viewed by ABCD members. The
results triggered a
BBC news item. there is a
webcast of the 1-year results including assessment of
impact on 10-year cardiovascular risk from the presentation
at ADA 2016. Click the link on the left for more
information. |
|
Nationwide
canagliflozin audit |
The nationwide Invocana®
audit launched in January 2016 as a second SGLT2 audit hosted
on N3 - the the national broadband network for the NHS. All
users of canagliflozin are invited to join the audit. Click
the link on the left for more information.
Click here to join the
canagliflozin, dapagliflozin and exenatide qw audits
with a single application. |
|
|
|
|
2015 |
|
|
National audit of DKA management |
The results of this audit, which
started in 2014, and which we believe is the largest ever
national survey on the management of DKA ever conducted,
were published in Diabetic Medicine in February 2016 in
a paper and
a letter. They showed that most hospitals (71%) who
returned data used the
JBDS guidelines (2a and 2b). The most common precipitant
for DKA was infection and a third of patients had at least 1
previous episode of DKA in the previous year. Of some
concern was that 7.8% of all of the reported cases occurred
in existing inpatients. The guidelines are used well during
the first hour after admission; however, later during the
hospital admission, observations were not carried out as
often as recommended. In addition, a significant minority
developed hypoglycaemia and 55% developed hypokalaemia at
some stage. It was difficult to know if this was because the
guidelines for fluid, glucose and electrolyte replacement
was not being followed as recommended, or if it was the
guideline that was at fault. Click the link on the left
for more information. |
|
|
|
|
2014 |
|
|
Nationwide insulin degludec audit |
The nationwide Tresiba®
audit launched at the ABCD autumn meeting in November 2014.
All users of insulin degludec are invited to join the audit.
Click the link on the left for more information. |
|
Nationwide dapagliflozin audit |
The nationwide Forxiga®
audit launched in October 2014 as a second audit hosted
on N3 - the the national broadband network for the NHS. All
users of dapagliflozin are invited to join the audit. Click
the link on the left for more information.
Click here to join the dapagliflozin and exenatide qw audits
with a single application. |
|
IDOP
and ABCD care homes audit |
The Institute of Diabetes for
Older People (IDOP) in association with ABCD has led a
national stakeholder audit of diabetes care in care homes.
Responses from more than 2000 care homes in England revealed
important gaps in screening for diabetes, hypoglycaemia
care, and the training and education of care staff in the
area of diabetes. The results of this audit have been passed
to the Care Quality Commission to assist them in developing
inspection processes for care homes. The report was
published in
June 2014 - click the link on the left. |
|
Nationwide exenatide qw audit |
The nationwide Bydureon®
audit launched in April 2014. The great step forward for
this audit is that it is the first ABCD audit to be hosted
on N3 - the the national broadband network for the NHS. All
users of exenatide QW are invited to join the audit. Click
the link on the left for more information. |
|
Nationwide liraglutide audit - ongoing since 2009 |
The audit is ongoing and now has
over 6000 patients. There have
been several
presentations at national and international
meetings and there are papers
published and being written. The
audit tool was upgraded in 2012 to become
secure online/web-based. All
users of liraglutide are invited to join the audit. |
|
ABCD
Scottish audit of inpatient diabetes care - ongoing since
2009 |
An audit of Inpatient Diabetes
Care across NHS Lothian: The effectiveness of the use of
information technology, the Scottish Patient Safety
Programme and ‘Think Glucose’. The results to date were
presented at ABCD autumn meeting in 2013 and
the slides from that
presentation are available to ABCD members |
|
|
|
|
2013 |
|
|
ABCD
multi-centre study of urinary C-peptide in liraglutide
treated patients |
ABCD multi-centre urinary C-peptide study aimed
to relate initial beta-cell function to response to
liragutide. It was led by previous ABCD research fellow, Dr
Ken Thong. The study showed that postprandial urinary
C-peptide creatinine ratio (UCPCR ) was associated with the
subsequent glycaemic response to liraglutide treatment, but
a clear cut-off UCPCR level that would help predict a
favourable glycaemic response was not identified. The
results were presented on a
poster at the ABCD Autumn meeting, 2013 and the full
results were
published in Diabetic Medicine in December 2013. |
|
ABCD/JDRF/Diabetes UK Insulin Pump Audit - 2011-2013 |
The joint ABCD/JDRF/Diabetes UK Insulin Pump Audit for the UK
surveyed diabetes centres in the UK, to establish basic data
on numbers and type of insulin pump starts and follow up,
and availability and use of CGMS. The audit was
published on
May 14, 2013, and revealed that the proportion of people in
the UK who live with type 1 diabetes and use a pump.
Publication was accompanied by a
press release
from JDRF and Diabetes UK, giving their reaction to the
audit’s findings and headlined “UK lagging behind Europe for
use of insulin pumps”. |
|
2012 |
|
|
ABCD
audits in 2012 |
All the audits started or
continuing during 2012 continued beyond that year |
|
|
|
|
2011 |
|
|
Nationwide exenatide audit |
6717 patients (2007-2009), 315 contributors, 126 centres.
Several papers now
published with more still being written and there have
been many presentations at national and international. |
|
2010 |
|
|
TITAN-ACS study |
THE TITAN-ACS STUDY is a joint venture between ABCD, NHS
Diabetes, British Cardiovascular Society, Myocardial
Ischaemia National Audit project (MINAP). It is a Trial of
Intravenous Insulin Infusion in the Management of
Hyperglycaemia in Acute Coronary Syndrome. |
|
2009 |
|
|
Pre-conception care and diabetes the impact of QoF |
This audit for which ABCD provided sponsorship in 2007-2008 was
presented at the ABCD Spring meeting in 2009. It looked at
the care of women with diabetes following the introduction
of QoF. It found that there are a significant number of
women with diabetes aged under 50. They have significant
co-morbidity. Their treatment is aimed at reducing long term
cardiovascular disease rather targeting more appropriate age
specific risk. |
|
2008 |
|
|
Nationwide audit of confidence among junior doctors in the
UK in management of diabetes |
A national audit on confidence levels, current practice and
perceived training needs of junior doctors in the UK. The
audit concluded that trainee doctors in the UK lack
confidence in the management of diabetes, are unlikely to
take the initiative to optimize glycaemic control and report
a need for further training. The project led to two
abstracts for posters, 2 presentations at national meetings
and 3 papers, the main publication being in QJM in 2010. |
|
2007 |
|
|
ABCD
multi-centre audit of hyperglycaemia management in ACS |
A multi-centre pilot audit of hyperglycaemic management in
acute coronary syndrome stimulated by the contrasting
findings between DIGAMI 1 and 2. Glycaemic care was found to
be variable within and between centres. |
|
Nationwide exubera audit |
This audit launched in 2007 was never completed because Exubera
was taken off the market |
|
2006 |
|
|
Nationwide audit of glitazone use with insulin |
A nationwide audits undertaken in 2005 and
presented as a poster at the ABCD meeting in Glasgow in
2006. The audit found that in extreme insulin resistance
some, but not all, patients responded to the combination
|
|
Nationwide audit of triple OHA use in insulin avoidance |
A nationwide audits undertaken in 2005 and
presented as a poster at the ABCD meeting in Glasgow in
2006. The audit demonstrated that the addition of glitazones
to metformin and sulphonylureas was often very effective and
allowed insulin to be avoided or postponed. |
|
Second national survey of UK specialist diabetes services |
As a follow up to the survey carried out in 2000 this survey
aimed to assess the extent of changes following the
introduction of national service frameworks and changes in
commissioning. The results can be viewed through several
presentations and publications |
|
ABCD sponsored audit of hypoglycaemia in the community |
This audit found that between 25 and 40% of ambulance call-outs
for hypoglycaemia are taken to A&E and approximately 40% of
these were admitted. There was poor communication between
ambulance / A&E and the diabetes team.
An update from the audit was presented at the ABCD Autumn
Meeting, 2012. |
|
2005 |
|
|
ABCD survey of inpatient diabetes services in the UK |
Of 262 Acute hospitals surveyed 239 (91.2%) provided data. The
survey identified substantial gaps in in-patient diabetes
care in the UK. However a rapid increase in DISN indicated
increasing attention to in-patient diabetes care. The
results were published in Diabetic Medicine in 2007. |
|
Nationwide audit of gestational diabetes screening |
A national audit of gestational diabetes screening and
glycaemic management. The findings were published in QJM in
2008 and showed that standards for GDM screening and
management vary significantly across the UK. |
|
2004 |
|
|
Nationwide audit of glargine in pregnancy |
This audit was published in Diabetic Medicine in 2008 and
suggested that the use of glargine in Type 1 diabetes during
pregnancy was not associated with any unexpected adverse
maternal or fetal outcome. |
|
2000 |
|
|
First national survey of UK specialist diabetes services |
An ambitious but successful attempt to assess the state of
diabetes specialist services at the turn of the century. The
survey was carried out in 1999 and extensive results are
given covering all aspects of diabetes |
|
Working to support high quality diabetes care in the
UK |
